MedTrace Logo

A Mindfulness Approach to UA for Afro-descendants

NCT05881681 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-03-15

No results posted yet for this study

Summary

The goal of this clinical trial is to test an app-based mindfulness training program in an Afro-descendant population. The main question\[s\] it aims to answer are:

* What changes, if any, does the app need?
* Is it effective in reducing anxiety among this population?

Participants will be asked to:

* Use an app-based mindfulness training program daily
* Complete online surveys at baseline and 2 months post-treatment initiation
* Complete focused interviews via Zoom at baseline and 2 months post-treatment initiation
* Complete daily voice diaries via Zoom

Conditions

Interventions

BEHAVIORAL

App-Delivered Mindfulness Training (MT)

Unwinding Anxiety is an app-delivered mindfulness training program which includes a progression through 30+ daily modules. Each module's training is delivered via short video tutorials and animations (\~10 min/day). Each training builds on the previous one; modules are 'locked' so that they can only be viewed at a pace of 1/day (previous modules can be reviewed at any time). A built-in self-assessment is taken after every seven modules to ensure key concepts are learned before moving on with automated suggestions on which modules to repeat based on the self-assessment results. User-initiated guided practices range from short exercises (30 seconds) to manage anxiety the moment it arises to formal guided meditations (up to 15 minutes), and can be accessed at any time

Sponsors & Collaborators

  • Richard King Mellon Foundation

    collaborator UNKNOWN

  • University of Pittsburgh Medical Center

    collaborator OTHER

  • Brown University

    lead OTHER

Principal Investigators

  • Judson A Brewer · Brown University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-06
Primary Completion
2024-02-05
Completion
2024-02-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05881681 on ClinicalTrials.gov